- Home
- CVM vs OKYO Comparison
CVM vs OKYO Comparison
Compare CVM & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- OKYO
- Stock Information
- Founded
- CVM 1983
- OKYO 2007
- Country
- CVM United States
- OKYO United Kingdom
- Employees
- CVM N/A
- OKYO N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CVM Health Care
- OKYO Health Care
- Exchange
- CVM Nasdaq
- OKYO Nasdaq
- Market Cap
- CVM 40.1M
- OKYO 38.6M
- IPO Year
- CVM 1987
- OKYO 2022
- Fundamental
- Price
- CVM $0.40
- OKYO $1.04
- Analyst Decision
- CVM
- OKYO Strong Buy
- Analyst Count
- CVM 0
- OKYO 1
- Target Price
- CVM N/A
- OKYO $7.00
- AVG Volume (30 Days)
- CVM 2.0M
- OKYO 93.8K
- Earning Date
- CVM 01-13-2025
- OKYO 01-28-2025
- Dividend Yield
- CVM N/A
- OKYO N/A
- EPS Growth
- CVM N/A
- OKYO N/A
- EPS
- CVM N/A
- OKYO N/A
- Revenue
- CVM N/A
- OKYO N/A
- Revenue This Year
- CVM N/A
- OKYO N/A
- Revenue Next Year
- CVM $152.91
- OKYO N/A
- P/E Ratio
- CVM N/A
- OKYO N/A
- Revenue Growth
- CVM N/A
- OKYO N/A
- 52 Week Low
- CVM $0.36
- OKYO $0.81
- 52 Week High
- CVM $3.08
- OKYO $1.90
- Technical
- Relative Strength Index (RSI)
- CVM 38.00
- OKYO 45.08
- Support Level
- CVM $0.37
- OKYO $1.00
- Resistance Level
- CVM $0.42
- OKYO $1.35
- Average True Range (ATR)
- CVM 0.04
- OKYO 0.10
- MACD
- CVM -0.00
- OKYO -0.01
- Stochastic Oscillator
- CVM 11.83
- OKYO 11.43
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The Company's core capabilities that include are drug discovery, research, development and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.